Vincent Woo MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
Join to View Full Profile
4309 W Medical Center DrSte A200Mchenry, IL 60050
Phone+1 815-759-8070
Fax+1 815-759-4931
Dr. Woo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Loyola University Medical CenterFellowship, Cardiovascular Disease, 2012 - 2015
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2009 - 2012
Saint Louis University School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - Present
IL State Medical License 2012 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 22 citations2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.G B John Mancini, Eileen O'Meara, Shelley Zieroth, Mathieu Bernier, Alice Y Y Cheng
The Canadian Journal of Cardiology. 2022-08-01 - 3 citationsFibrous Cap Thickness Predicts Stable Coronary Plaque Progression: Early Clinical Validation of a Semiautomated OCT Technology.Nicholas Kassis, Tomas Kovarnik, Zhi Chen, Joseph R Weber, Brendan Martin
Journal of the Society for Cardiovascular Angiography & Interventions. 2022-07-13 - 3 citationsA Rare Case of RYR2 Mutation Causing Sudden Cardiac Arrest Due to Catecholaminergic Polymorphic Ventricular Tachycardia.Lalitha Padmanabha Vemireddy, Ammar Aqeel, Grace W Ying, Delaram Majlesi, Vincent Woo
Cureus. 2021-02-18
Press Mentions
Type 2 Diabetes and Cardiovascular Disease PreventionNovember 2nd, 2018
INVOKANA® (Canagliflozin) Significantly Reduces the Combined Risk of Cardiovascular Death, Myocardial Infarction, and Stroke in the CANVAS ProgramJune 12th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
